Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.

Clinical trial NCT00298350 · COMPLETED

Trial details

NCT number: NCT00298350
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV HIV-1 Human Immunodeficiency Virus

Start date: 2006-02-01
Primary completion: 2007-06-01
Enrollment: 278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.